The cancer vaccines market is majorly driven by the rising prevalence of cancer and increasing demand for effective prevention and therapeutics across the world. According to the World Cancer Research Fund, in 2018, there were an estimated 18 million cancer cases across the world, of which, 9.5 million cases were in men and 8.5 million in women. The need for cancer prevention and treatment has been increasing over the years, and more than 11 million people are being diagnosed with cancer every year. According to the Global Cancer Observatory 2018, the number is projected to increase to 27.5 new cancer cases by 2040. Due to the rising prevalence of cancer in every part of the world, various governments and research organizations established initiatives for cancer awareness. These initiatives illustrate various approaches for preventing and monitoring cancer. This is likely to drive the market’s growth over the forecast period.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6. COMPETITIVE LANDSCAPE AND COMPANY PROFILES

7. MARKET OPPORTUNITIES AND FUTURE TRENDS